Cresten Labs is a research peptide supplier serving European laboratories, qualified accredited researchers, and longevity research groups. The operation is built around a single question: how does a European supplier publish verification that customers can actually trust. Every batch ships with a certificate from an third-party laboratory, posted on this site with the batch before it lists. Analytical work is run with Janoshik Analytical in Czech Republic, fulfilment is handled inside the EU single market, and editorial work is produced in-house. The legal operating entity is Meridian Land Ventures LLC, a Delaware company trading as Cresten Labs.
Bachem and Tocris exist for big institutional buyers with purchase orders. Their work is serious. Neither serves the smaller laboratory, the contract research organisation, or the qualified accredited researcher operating outside a large institution. Particle Peptides, Semax Polska, and a handful of other European vendors operate at smaller scale, but none publish third-party certificates before stock goes on sale, and none carry the depth of testing that a serious acquirer eventually expects.
I spent years sourcing research material inside European pharmaceutical and analytical supply chains before starting this. The same pattern kept turning up. Certificates written by the same vendor that sold the material. Batch numbers an outside party could not check. A different lab from one batch to the next, so the numbers never lined up. And no way to hold a vial in your hand and confirm it against a public record.
"A certificate of analysis is not really a certificate when it is written by the same party that sold the material."
So I built the supplier I wanted to buy from, and we run it to one rule we will not bend: a batch is tested before it lists, and its certificate is published with it before it goes on sale. Not a certificate we wrote. One from an lab, with the batch number on it, that you can check yourself. Janoshik Analytical, in Brno, is one of the laboratories whose reports we publish, and we commission additional Janoshik checks on selected batches as a quality control layer above the supplier certificate. The standard is simple: a certificate goes up before the batch is released for shipment, every vial carries a QR code that opens its public verification page, and the digital fingerprint of each certificate is posted to a public record the day it goes live, so it cannot be quietly changed later without breaking the fingerprint. The chain is short, public, and honest.
Compounds are made at a partner facility inside the European Union. We are not naming the specific partner facility in public during the first year. This is a deliberate choice about how we run the company, not a sales line. Qualified institutional buyers and serious acquirer teams receive the partner’s name under a standard non-disclosure agreement as part of normal due diligence.
Every batch ships with a certificate from an accredited analytical laboratory. Janoshik Analytical, in Brno, Czech Republic, is one of the labs whose reports we publish. Janoshik is referenced across the European research peptide community as one of the most strict accredited peptide testing labs working outside the institutional pharmaceutical supply chain. Where Janoshik testing is on file for a batch, we publish that report. Reports from any lab we accept are issued in standard form, signed, and dated.
All compounds are supplied in freeze-dried vials only. We do not currently supply pre-filled peptide pens, capsules, or nasal sprays. Any new formats we add in future will have to meet the same testing standard that the freeze-dried vial format meets today. Pre-filled formats are deliberately not included in the launch catalogue.
Orders ship from European Union, to a defined list of EU member states in the current operating phase. The full served list with transit times is on the Shipping page. Markets outside the current operating phase are added as carrier integrations and operational requirements for each market are completed.
You do not have to take our certificate on faith. Any buyer who wants to commission accredited re-testing on a Cresten batch is welcome to, and Janoshik is one of the labs we would point you to. Where the certificate on file came from Janoshik, the report identifier we publish is the same one Janoshik issued, so it reconciles on their side, not just ours.
The rule is that the digital fingerprint of each certificate we publish goes to a public record the day the certificate goes live, before any vial of that batch ships. The record is publicly readable, and the fingerprint on the certificate has to match the fingerprint in the record. How this works is shown on a sample verification page.
Questions about a compound, a certificate of analysis, a batch, or an order. We reply by email, typically the same working day.
Regulatory inquiries, compliance verification, suspected misuse reports. Routed to the appropriate team member with confidentiality maintained.
Trademark inquiries, intellectual property correspondence, legal counsel reaching the company on behalf of a third party.
Institutional buyers, registered laboratories, clinic suppliers, B2B partners. Reply with appropriate verification within two business days.
No sales chat, no funnel, no upsell. We are a research compound supplier, and the contact paths above reach the people who do the work.
This site presents technical and editorial content on research compounds. Compounds are supplied for in-vitro and preclinical research only, not for human or veterinary use. Access is restricted to adults of confirmed age.
